Katie A Greenzang1,2,3, Karen M Fasciano4,5, Susan D Block4,5,6, Jennifer W Mack1,2,3. 1. Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. 2. Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. 3. Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts, USA. 4. Department of Psychosocial Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. 5. Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, USA. 6. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Abstract
BACKGROUND: Adolescent and young adult (AYA) cancer survivors have high risks of late effects. Little is known about the late-effect information needs of AYAs early in treatment or their role in treatment decision making. This study evaluated the importance, quality, and implications of information about late effects in AYAs recently diagnosed with cancer. METHODS: This study surveyed 201 AYAs with cancer who were 15 to 29 years old and were treated at the Dana-Farber Cancer Institute (Boston, Massachusetts). Patients were approached within 6 weeks of their diagnosis and were asked about their late-effect and infertility information needs, treatment decision making, and communication outcomes. RESULTS: Forty-five percent of the participants were female; 88% were white. Most AYAs (87% [173 of 200]) considered information about the risks of late effects to be extremely or very important; 80% (159 of 200) valued information about infertility. Many were distressed by information about late effects (53% [105 of 200]) and infertility (45% [89 of 200]); those who considered late-effect information distressing were more likely to value this information (P < .0001). Consideration of late effects (41% [82 of 201]) and infertility (36% [72 of 201]) greatly influenced many patients' treatment decision making. Although 92% of the patients (184 of 199) reported receiving high-quality information about the diagnosis, 57% (113 of 199; P < .0001) and 65% (130 of 199; P < .0001) felt that they had received high-quality information about late effects and infertility, respectively. CONCLUSIONS: Most AYAs with cancer value early information about the risks of late effects and infertility, yet many patients felt that they had not received high-quality information about these topics. The development of age-appropriate late-effect communication strategies that recognize high AYA distress may help to address the gap between desired information and perceived information quality.
BACKGROUND: Adolescent and young adult (AYA) cancer survivors have high risks of late effects. Little is known about the late-effect information needs of AYAs early in treatment or their role in treatment decision making. This study evaluated the importance, quality, and implications of information about late effects in AYAs recently diagnosed with cancer. METHODS: This study surveyed 201 AYAs with cancer who were 15 to 29 years old and were treated at the Dana-Farber Cancer Institute (Boston, Massachusetts). Patients were approached within 6 weeks of their diagnosis and were asked about their late-effect and infertility information needs, treatment decision making, and communication outcomes. RESULTS: Forty-five percent of the participants were female; 88% were white. Most AYAs (87% [173 of 200]) considered information about the risks of late effects to be extremely or very important; 80% (159 of 200) valued information about infertility. Many were distressed by information about late effects (53% [105 of 200]) and infertility (45% [89 of 200]); those who considered late-effect information distressing were more likely to value this information (P < .0001). Consideration of late effects (41% [82 of 201]) and infertility (36% [72 of 201]) greatly influenced many patients' treatment decision making. Although 92% of the patients (184 of 199) reported receiving high-quality information about the diagnosis, 57% (113 of 199; P < .0001) and 65% (130 of 199; P < .0001) felt that they had received high-quality information about late effects and infertility, respectively. CONCLUSIONS: Most AYAs with cancer value early information about the risks of late effects and infertility, yet many patients felt that they had not received high-quality information about these topics. The development of age-appropriate late-effect communication strategies that recognize high AYA distress may help to address the gap between desired information and perceived information quality.
Authors: Kutluk Oktay; Brittany E Harvey; Ann H Partridge; Gwendolyn P Quinn; Joyce Reinecke; Hugh S Taylor; W Hamish Wallace; Erica T Wang; Alison W Loren Journal: J Clin Oncol Date: 2018-04-05 Impact factor: 44.544
Authors: Theresa H M Keegan; Daphne Y Lichtensztajn; Ikuko Kato; Erin E Kent; Xiao-Cheng Wu; Michelle M West; Ann S Hamilton; Brad Zebrack; Keith M Bellizzi; Ashley W Smith Journal: J Cancer Surviv Date: 2012-03-29 Impact factor: 4.442
Authors: Iqra A Syed; Anne F Klassen; Ronald Barr; Rebecca Wang; David Dix; Marion Nelson; Zahava R S Rosenberg-Yunger; Paul C Nathan Journal: J Cancer Surviv Date: 2015-09-04 Impact factor: 4.442
Authors: Meaghann S Weaver; Justin N Baker; Jami S Gattuso; Deborah V Gibson; April D Sykes; Pamela S Hinds Journal: Cancer Date: 2015-09-08 Impact factor: 6.860
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison Journal: N Engl J Med Date: 2006-10-12 Impact factor: 176.079
Authors: Katie A Greenzang; Colleen A Kelly; Hasan Al-Sayegh; Clement Ma; Jennifer W Mack Journal: Pediatr Blood Cancer Date: 2021-09-14 Impact factor: 3.167
Authors: Wai Hoong Chang; Michail Katsoulis; Yen Yi Tan; Stefanie H Mueller; Katherine Green; Alvina G Lai Journal: Lancet Reg Health Eur Date: 2021-11-14
Authors: Bryan A Sisk; Ginny L Schulz; Erica C Kaye; Justin N Baker; Jennifer W Mack; James M DuBois Journal: J Palliat Med Date: 2021-07-13 Impact factor: 2.947
Authors: Bryan A Sisk; Megan A Keenan; Lindsay J Blazin; Erica Kaye; Justin N Baker; Jennifer W Mack; James M DuBois Journal: Pediatr Blood Cancer Date: 2021-04-16 Impact factor: 3.838